Young R E, Voisin M-B, Wang S, Dangerfield J, Nourshargh S
Cardiovascular Medicine Unit, National Heart & Lung Institute, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, UK.
Br J Pharmacol. 2007 Jul;151(5):628-37. doi: 10.1038/sj.bjp.0707267. Epub 2007 Apr 30.
The serine protease neutrophil elastase (NE) appears to regulate inflammatory responses at multiple levels but its role in leukocyte transmigration in vivo remains unclear. The present study aimed to address this issue by using both an NE inhibitor (ONO-5046) and NE deficient (NE(-/-)) mice.
A number of inflammatory mediators (LTB(4), KC and PAF) were investigated in vitro for their ability to stimulate the release and the surface expression of NE by neutrophils. In addition, the role of NE in leukocyte migration elicited by topical LTB(4) was investigated in vivo in mouse cremasteric venules as observed by intravital microscopy.
Amongst the mediators tested in vitro, LTB(4) was found to be a highly potent and efficacious inducer of NE cell surface expression on murine neutrophils. Furthermore, in wild-type mice (WT), LTB(4)-induced leukocyte transmigration was reduced by intravenous ONO-5046 (66% inhibition), an effect that appeared to occur at the level of the perivascular basement membrane. Interestingly, LTB(4)-induced responses were normal in NE(-/-) mice and, while ONO-5046 had no inhibitory effect in these animals, the broad-spectrum serine protease inhibitor aprotinin suppressed leukocyte transmigration in both WT and NE(-/-) mice.
The findings demonstrate the potent ability of LTB(4) to induce cell-surface expression of NE and provide evidence for the involvement of NE in LTB(4)-induced neutrophil transmigration in vivo. The results also suggest the existence of compensatory mechanisms in NE(-/-) mice, highlighting the added value of investigating pharmacological blockers in parallel with genetic deletion.
丝氨酸蛋白酶中性粒细胞弹性蛋白酶(NE)似乎在多个水平调节炎症反应,但其在体内白细胞迁移中的作用仍不清楚。本研究旨在通过使用NE抑制剂(ONO-5046)和NE缺陷(NE(-/-))小鼠来解决这一问题。
在体外研究了多种炎症介质(LTB(4)、KC和PAF)刺激中性粒细胞释放NE和使其表面表达NE的能力。此外,通过活体显微镜观察,在小鼠提睾肌微静脉中研究了NE在局部应用LTB(4)引发的白细胞迁移中的作用。
在体外测试的介质中,发现LTB(4)是小鼠中性粒细胞NE细胞表面表达的高效诱导剂。此外,在野生型小鼠(WT)中,静脉注射ONO-5046可减少LTB(4)诱导的白细胞迁移(抑制率66%),这种作用似乎发生在血管周围基底膜水平。有趣的是,LTB(4)诱导的反应在NE(-/-)小鼠中正常,虽然ONO-5046在这些动物中没有抑制作用,但广谱丝氨酸蛋白酶抑制剂抑肽酶在WT和NE(-/-)小鼠中均抑制白细胞迁移。
这些发现证明了LTB(4)诱导NE细胞表面表达的强大能力,并为NE参与体内LTB(4)诱导的中性粒细胞迁移提供了证据。结果还表明NE(-/-)小鼠中存在补偿机制,突出了与基因缺失并行研究药物阻滞剂的附加价值。